| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 193 |
| 1 | CLOPIDOGREL | 131 |
| 2 | ASPIRIN | 125 |
| 3 | ASPIRIN 325 MG | 121 |
| 4 | ASPIRIN 81 MG | 121 |
| 5 | RIVAROXABAN | 98 |
| 6 | CLOPIDOGREL BISULFATE | 91 |
| 7 | APIXABAN | 80 |
| 8 | METOPROLOL TARTRATE | 78 |
| 9 | METFORMIN | 76 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANDEXANET ALFA | 5 | 0.0071 |
| 1 | BARICITINIB | 13 | 0.0043 |
| 2 | PENTOXIFYLLINE | 16 | 0.0037 |
| 3 | CILOSTAZOL | 22 | 0.0035 |
| 4 | NILOTINIB | 66 | 0.0022 |
| 5 | ARGATROBAN | 3 | 0.0020 |
| 6 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 3 | 0.0018 |
| 7 | COLLAGENASE SANTYL | 3 | 0.0018 |
| 8 | ASCIMINIB | 6 | 0.0017 |
| 9 | DAPRODUSTAT | 3 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 175 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 162 |
| 2 | Corticosteroid [EPC] | 155 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 126 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 99 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 96 |
| 6 | Insulin Analog [EPC] | 84 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 82 |
| 8 | Loop Diuretic [EPC] | 74 |
| 9 | Proton Pump Inhibitor [EPC] | 72 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 1 | Blood Viscosity Reducer [EPC] | 16 | 0.0037 |
| 2 | Phosphodiesterase 3 Inhibitor [EPC] | 22 | 0.0035 |
| 3 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 4 | 0.0018 |
| 5 | PCSK9 Inhibitor [EPC] | 38 | 0.0015 |
| 6 | Provitamin D2 Compound [EPC] | 42 | 0.0014 |
| 7 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 8 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 9 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |